Halozyme Therapeutics
HALO
#2435
Rank
HK$56.61 B
Marketcap
HK$481.42
Share price
-1.61%
Change (1 day)
26.22%
Change (1 year)

Market capitalization of Halozyme Therapeutics (HALO)

Market cap: HK$56.61 Billion

As of December 2025 Halozyme Therapeutics has a market cap of HK$56.61 Billion. This makes Halozyme Therapeutics the world's 2435th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Halozyme Therapeutics from 2004 to 2025

End of year Market Cap

Year Marketcap Change
2025HK$56.61 B19.09%
2024HK$47.53 B24.67%
2023HK$38.13 B-36.57%
2022HK$60.11 B36.18%
2021HK$44.14 B-1.38%
2020HK$44.75 B137.1%
2019HK$18.87 B13.85%
2018HK$16.58 B-26.42%
2017HK$22.53 B127.13%
2016HK$9.92 B-42.37%
2015HK$17.21 B82.92%
2014HK$9.41 B-29.32%
2013HK$13.31 B127.11%
2012HK$5.86 B-23.46%
2011HK$7.65 B23.55%
2010HK$6.19 B48.56%
2009HK$4.17 B18.4%
2008HK$3.52 B-18.39%
2007HK$4.31 B0.35%
2006HK$4.30 B406.21%
2005HK$0.85 B1.06%
2004HK$0.84 B

End of Day market cap according to different sources

On Dec 9th, 2025 the market cap of Halozyme Therapeutics was reported to be:

HK$56.61 Billion
by Nasdaq info icon info icon
HK$56.61 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
MannKind Corp
MNKD
HK$13.78 B-75.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$6.851 T 12,002.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
HK$72.63 B 28.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$1.120 T 1,879.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$908.44 B 1,504.64%๐Ÿ‡ซ๐Ÿ‡ท France
Johnson & Johnson
JNJ
HK$3.748 T 6,521.51%๐Ÿ‡บ๐Ÿ‡ธ USA